Asia-Pacific Cell and Gene Therapy Biomanufacturing Forecast Report to 2031 - WuXi AppTec Dominates the Market

DUBLIN, Jan. 31, 2024 /PRNewswire/ -- The "Asia-Pacific Cell and Gene Therapy Biomanufacturing Market - Analysis and Forecast, 2022-2031" report has been added to's offering.

The global healthcare sector observes a momentous shift with the new research publication unveiling comprehensive insights into the Asia-Pacific Cell and Gene Therapy Biomanufacturing Market. This pivotal analysis anticipates a soaring Compound Annual Growth Rate (CAGR) of 17.88% from 2022 to 2031, marking a prolific increase from $1.96 billion to a staggering $8.60 billion.

Impetus for the Market Expansion

Factors propelling the market growth are cited to be the surge in authorized treatments and the burgeoning need for advanced biomanufacturing infrastructures capable of catering to an expanding array of target indications for cell and gene therapies.

Significant investments by governments, pharmaceutical giants, and academic institutions in the APAC region are setting the stage for novel breakthroughs in medical treatments, thereby fuelling the demand for sophisticated biomanufacturing solutions.

Market Segmentation

The report meticulously segments the market to furnish a granular analysis of the industry dynamics. The segmentation delves into:

    --  Product Type, including Consumables, Equipment, and Software Solutions
    --  End Users such as Life Science Companies, Contract Research
        Organizations (CROs), Contract Manufacturing Organizations (CMOs), and
        Cell Banks
    --  Geographical distribution spanning China, Japan, India, South Korea,
        Australia/New Zealand, and the broader Rest-of-Asia-Pacific region

Strategic Analysis for Market Participants

For entities participating in the APAC market, the report presents an invaluable resource for formulating workflow and innovation strategies, as well as for guiding growth and marketing efforts to capture the emergent opportunities in cell and gene therapy biomanufacturing.

Industry Drivers and Challenges

Among the primary drivers underpinning the market's promising outlook are:

    --  The ongoing expansion in target indications requiring large-scale
        biomanufacturing capabilities.
    --  The influx of new market entrants necessitating a robust infrastructure
        for biomanufacturing.
    --  A robust clinical pipeline further demanding enhanced biomanufacturing

Conversely, the market must navigate through challenges such as the high initial setup costs associated with biomanufacturing facilities.

Competitive Landscape and Key Market Innovators

Comprehensive profiling of leading market contributors reveals the competitive strategic landscapes. This analysis highlights the key players' innovative product launches, acquisitions, expansions, and strategic collaborations, offering a competitive benchmarking that elucidates the position of each market player.

Potential for Transformational Impact

Encompassing a period of rapid industrial change and projected growth, the findings within the report underscore the Asia-Pacific region's critical role in the global biomanufacturing landscape.

With the market poised for exponential growth, stakeholders across the healthcare and biotechnology sectors are set to witness an era marked by groundbreaking advancements and strategic market shifts in cell and gene therapy biomanufacturing.

Key Market Segmentation:

Segmentation by Product Type

    --  Consumables
    --  Equipment
    --  Software Solutions

Segmentation by End User

    --  Life Science Companies
    --  Contract Research Organizations (CROs)
    --  Contract Manufacturing Organizations (CMOs)
    --  Cell Banks

Segmentation by Country

    --  China
    --  Japan
    --  India
    --  South Korea
    --  Australia/New Zealand
    --  Rest-of-Asia-Pacific

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


View original content:

SOURCE Research and Markets